Fré Pharma SRL
The score of Fré Pharma shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Equity +27 % Total assets -37 %
Accounts of the company itself (not consolidated).
The full file covers 10 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
Fré Pharma's annual accounts
Filed annual accounts
- Year ended 31 Mar 2025filed on 29 Sep 2025
- Year ended 31 Mar 2024filed on 04 Nov 2024
- Year ended 31 Mar 2023filed on 07 Nov 2023
- Year ended 31 Mar 2022filed on 28 Oct 2022
- Year ended 31 Mar 2021filed on 30 Nov 2021
Fré Pharma's financial analysis
- Solvency43.4%sector median: 58.9%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of Fré Pharma
Fré Pharma's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0849.038.129
- VAT number
- BE0849038129
- Peppol
- Registered · 0208:0849038129 · as of 09 Nov 2026
- Legal form
- SRL
- Incorporated
- 26 Sep 2012
- Registered office
- 3052 Oud-Heverlee
- Latest accounts
- 2025 · filed on 29 Sep 2025
- Activity
- Business and other management consultancy activities (NACE 70200)
Fré Pharma (SRL) has been based in Oud-Heverlee since 2012, active in: business and other management consultancy activities. For 2025, it reports a net profit of 40,263 € and equity of 546,583 €; its revenue is not published. Its solvency stands at 43.4%, below the median of its sector (58.9%).
Companies similar to Fré Pharma
Companies in the same business, of comparable size and area, outside its group.
- B-Assist Business and other management consultancy activities Hasselt · balance sheet €1.25m
- Mundus Magnus Business and other management consultancy activities Deinze · balance sheet €1.28m
- Sparkl Business and other management consultancy activities Villers-la-Ville · balance sheet €1.29m
- Enowenn Business and other management consultancy activities Namur · balance sheet €1.32m
- Wallimmo Business and other management consultancy activities Mons · balance sheet €1.20m
- Calycé Business and other management consultancy activities Sprimont · balance sheet €1.35m
- Albest Business and other management consultancy activities Geraardsbergen · balance sheet €1.35m
- Ingwer Business and other management consultancy activities Zemst · balance sheet €1.17m
Frequently asked questions about Fré Pharma
What is the revenue of Fré Pharma?
Fré Pharma files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of Fré Pharma?
In Belgium, the VAT number is the company number prefixed with BE: BE0849038129 for Fré Pharma, if the company is VAT-registered. Its company number (CBE) is 0849.038.129.
Where is the registered office of Fré Pharma?
According to the CBE register, the registered office of Fré Pharma is in 3052 Oud-Heverlee.
What is the equity of Fré Pharma?
At the close of the 2025 financial year, the equity of Fré Pharma amounts to 546,583 €, a solvency of 43.4% of total assets.
Who manages Fré Pharma?
The register lists 1 active mandates at Fré Pharma. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of Fré Pharma
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →